Interferon therapy in multiple myeloma.
Alpha-interferon is an active agent in multiple myeloma. It proved to be beneficial in some but not all studies both in combined therapy with alkylating agents or as a single agent to prolong the plateau phase in patients in partial remission. The best strategy of administration has yet to be established.
Brouet
J C
JC
Service d'Immunopathologie et d'Hématologie, Hôpital Saint Louis, Paris, France.
D000477:Alkylating Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000628:therapy*
D000477:Alkylating Agents; D016898:Interferon-alpha